Arata Itoh
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Observational study of the relationship between the use of real-time continuous glucose monitoring and glycemic control in patients with diabetes in Japan: the REALJ study.
Journal: Endocrine journal
Published: August 19, 2026
Sex differences in the impact of structured education together with isCGM in individuals with type 1 diabetes:post hoc analysis of the ISCHIA study.
Journal: The journal of medical investigation : JMI
Published: April 23, 2026
Difference in the accuracy of the third-generation algorithm and the first-generation algorithm of FreeStyle Libre continuous glucose monitoring device.
Journal: The journal of medical investigation : JMI
Published: October 27, 2024
Diurnal variation in the association between the scan frequency of isCGM and CGM metrics: post hoc analysis of the ISCHIA study.
Journal: Diabetology international
Published: April 27, 2024
A sensor-augmented pump with a predictive low-glucose suspend system could lead to an optimal time in target range during pregnancy in Japanese women with type 1 diabetes.
Journal: Diabetology international
Published: October 17, 2023
Maternal circadian rhythms during pregnancy dictate metabolic plasticity in offspring.
Journal: Cell metabolism
Published: August 07, 2023
Could the development of COVID-19 vaccine-induced type 1 diabetes be explained by a simple mechanism?
Journal: Diabetes & metabolism
Published: February 15, 2022
Newly developed type 1 diabetes after coronavirus disease 2019 vaccination: A case report.
Journal: Journal of diabetes investigation
Published: December 13, 2021
Enhancing Antigen Presentation and Inducing Antigen-Specific Immune Tolerance with Amphiphilic Peptides.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: November 06, 2019
Soluble CD137 Ameliorates Acute Type 1 Diabetes by Inducing T Cell Anergy.
Journal: Frontiers in immunology
Published: August 08, 2019
Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes.
Journal: ImmunoTargets and therapy
Published: June 06, 2017
Last Updated: 09/26/2026